Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
出版年份 2020 全文链接
标题
Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 122, Issue 9, Pages 1342-1353
出版商
Island Press
发表日期
2020-03-16
DOI
10.1038/s41416-020-0783-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer cells stemness: A doorstep to targeted therapy
- (2019) Sahdeo Prasad et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop
- (2019) Ke Xu et al. MOLECULAR THERAPY
- CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients
- (2018) Rongyong Huang et al. MEDICINE
- Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
- (2018) Lan Thi Hanh Phi et al. Stem Cells International
- Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
- (2018) Sònia Palomeras et al. MOLECULES
- Overcoming transporter-mediated multidrug resistance in cancer: failures and achievements of the last decades
- (2018) Miglė Paškevičiūtė et al. Drug Delivery and Translational Research
- Multifaceted Interpretation of Colon Cancer Stem Cells
- (2017) Yuichiro Hatano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy
- (2017) Guifa Xi et al. Molecular Cancer
- MACC1 facilitates chemoresistance and cancer stem cell-like properties of colon cancer cells through the PI3K/AKT signaling pathway
- (2017) Jiankai Wang et al. Molecular Medicine Reports
- Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer
- (2017) Andrew Fesler et al. Epigenomics
- Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers
- (2017) Yong Seok Kim et al. Expert Review of Gastroenterology & Hepatology
- Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles
- (2016) Sin-Tzu Ning et al. ACS Applied Materials & Interfaces
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
- (2016) Zhaolin Chen et al. CANCER LETTERS
- Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?
- (2016) Qian Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks inex vivoculture
- (2016) Fanny Grillet et al. GUT
- Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells
- (2016) Flaria El Khoury et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Downregulation of DNA-PKcs suppresses P-gp expression via inhibition of the Akt/NF-κB pathway in CD133-positive osteosarcoma MG-63 cells
- (2016) Ka Li et al. ONCOLOGY REPORTS
- Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways
- (2016) Gemma Leon et al. PHARMACOLOGY & THERAPEUTICS
- Sinapine reverses multi-drug resistance in MCF-7/dox cancer cells by downregulating FGFR4/FRS2α-ERK1/2 pathway-mediated NF-κB activation
- (2016) Ying Guo et al. PHYTOMEDICINE
- Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF-κB and p38 MAPK signaling pathways
- (2016) Rui Zhang et al. Oncology Letters
- High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models
- (2015) Rute B. Marques et al. EUROPEAN UROLOGY
- Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody
- (2015) Lei Zhao et al. JOURNAL OF IMMUNOTHERAPY
- Aβ1–42 reduces P-glycoprotein in the blood–brain barrier through RAGE–NF-κB signaling
- (2014) R Park et al. Cell Death & Disease
- Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma
- (2013) Anna Alisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment
- (2013) Guifa Xi et al. Nanomedicine-Nanotechnology Biology and Medicine
- CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2013) Shicai Chen et al. PLoS One
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multi-modal strategies for overcoming tumor drug resistance: Hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology
- (2011) Lara Milane et al. JOURNAL OF CONTROLLED RELEASE
- Multiple Drug Resistance Mechanisms in Cancer
- (2010) Bruce C. Baguley MOLECULAR BIOTECHNOLOGY
- An overview of cancer multidrug resistance: a still unsolved problem
- (2008) H. Lage CELLULAR AND MOLECULAR LIFE SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started